186 related articles for article (PubMed ID: 31664787)
1. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
2. CA15.3, CEA and LDH in dogs with malignant mammary tumors.
Campos LC; Lavalle GE; Estrela-Lima A; Melgaço de Faria JC; Guimarães JE; Dutra ÁP; Ferreira E; de Sousa LP; Rabelo ÉM; Vieira da Costa AF; Cassali GD
J Vet Intern Med; 2012; 26(6):1383-8. PubMed ID: 23113715
[TBL] [Abstract][Full Text] [Related]
3. Determination of carcinoembryonic antigen and cancer antigen (CA 15-3) in bitches with tumours on mammary gland: preliminary report.
Valencakova-Agyagosova A; Frischova Z; Sevcikova Z; Hajurka J; Lepej J; Szakallova I; Kredatusova G; Nagy V; Ledecky V
Vet Comp Oncol; 2014 Sep; 12(3):205-14. PubMed ID: 22947252
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients.
Fan Y; Ren X; Liu X; Shi D; Xu E; Wang S; Liu Y
Sci Rep; 2021 Mar; 11(1):6651. PubMed ID: 33758208
[TBL] [Abstract][Full Text] [Related]
5. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
6. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
[TBL] [Abstract][Full Text] [Related]
7. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
10. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
11. The utility of serum tumor markers CEA and CA 15-3 for breast cancer prognosis and their association with clinicopathological parameters.
Uygur MM; Gümüş M
Cancer Treat Res Commun; 2021; 28():100402. PubMed ID: 34082362
[TBL] [Abstract][Full Text] [Related]
12. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.
Molina R; Jo J; Filella X; Zanon G; Pahisa J; Mu noz M; Farrus B; Latre ML; Escriche C; Estape J; Ballesta AM
Breast Cancer Res Treat; 1998 Sep; 51(2):109-19. PubMed ID: 9879773
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
[TBL] [Abstract][Full Text] [Related]
15. Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours.
Yamagami T; Kobayashi T; Takahashi K; Sugiyama M
J Small Anim Pract; 1996 Oct; 37(10):462-4. PubMed ID: 8912239
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy.
Banchi P; Morello EM; Bertero A; Ricci A; Rota A
Vet Comp Oncol; 2022 Mar; 20(1):172-178. PubMed ID: 34351034
[TBL] [Abstract][Full Text] [Related]
17. Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
Elfagieh M; Abdalla F; Gliwan A; Boder J; Nichols W; Buhmeida A
Tumour Biol; 2012 Dec; 33(6):2371-7. PubMed ID: 22948780
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
20. Role of body condition score and adiponectin expression in the progression of canine mammary carcinomas.
Tesi M; Millanta F; Poli A; Mazzetti G; Pasquini A; Panzani D; Rota A; Vannozzi I
Vet Med Sci; 2020 Aug; 6(3):265-271. PubMed ID: 32202386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
